(1)
Design, Synthesis and Evaluation of CNS Depressant Activity of 2-(Substituted Aryl)-Piperazine-3-Phenyl-4(3H)-Quinazolinone. Int. J. Pharm. Sci. Drug Res. 2023, 15 (2), 209-213. https://doi.org/10.25004/IJPSDR.2023.150213.